-
Published 3/20/2025
Livingston NA, Mandavia AD, Banducci AN, Sistad Hall R, Loeffel LB, Davenport M, Mathes-Winnicki B, Ting M, Roth CE, Sarpong A, Newberger N, Hinds Z, Fonda JR, Chen D, Meng F. Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data. J Psychopathol Clin Sci. 2025 May; 134(4):448-457. PMID: 40111824.
-
Published 3/19/2025
Mandavia AD, Banducci AN, Simpson TL, Marx BP, Hawn SE, Hyde J, Ameral VE, Sistad Hall RE, Roth CE, Sarpong AA, Davenport M, Meng F, Stein MD, Livingston NA. Sex Differences in Suicide, Lethal Means, and Years of Potential Life Lost Among Veterans With Substance Use Disorder. Womens Health Issues. 2025 Mar 19. PMID: 40113455.
-
Published 10/31/2024
Livingston NA, Mandavia AD, Banducci AN, Loeffel LB, Hall RS, Maloney M, Roth CE, Fonda JR, Davenport M, Meng F, Hyde J, Stein M. Emergency department visits, inpatient hospitalizations, and non-fatal and fatal drug overdoses during COVID-19 among Veterans with opioid use disorder. J Stud Alcohol Drugs. 2024 Oct 31. PMID: 39480692.
-
Published 10/20/2023
Livingston NA, Sarpong A, Sistad R, Roth C, Banducci AN, Simpson T, Hyde J, Davenport M, Weisberg R. Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study. J Subst Use Addict Treat. 2024 Jan; 156:209188. PMID: 37866437.
-
Published 11/1/2022
Livingston NA, Davenport M, Head M, Henke R, LeBeau LS, Gibson TB, Banducci AN, Sarpong A, Jayanthi S, Roth C, Camacho-Cook J, Meng F, Hyde J, Mulvaney-Day N, White M, Chen DC, Stein MD, Weisberg R. The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. Drug Alcohol Depend. 2022 Dec 01; 241:109678. PMID: 36368167.